Evidence map›Paper›PMID 21190667›Full record

ArticleBiophysical journal2011

Investigating the refolding pathway of human acidic fibroblast growth factor (hFGF-1) from the residual structure(s) obtained by denatured-state hydrogen/deuterium exchange.

Han-Min Wang, Chin Yu

Abstract read
In one paragraph

Article in Biophysical journal, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Han-Min WangDepartment of Chemistry, National Tsing-Hua University, Hsin-Chu, Taiwan, Republic of China.
Chin Yu

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human fibroblast growth factor 1 (hFGF-1) consists of 12 anti-parallel β-strands arranged into a β-trefoil architecture. We directly measured hydrogen/deuterium exchange rates on the urea-denatured hFGF-1 to obtain the information with regard to the persistent residual interaction(s) in the unfolded hFGF-1. Thirty-eight residues whose heteronuclear single quantum coherence cross-peaks can be observed after exchange show higher protections than those predicted for the same residues in a random coil conformation, suggesting the existence of residual structure(s). The urea-denaturation of hFGF-1 tested by both circular dichroism and fluorescence spectroscopy indicated that the unfolding process is a cooperative two-state process and that the residual structures observed did not originate from the existence of a partially structured intermediate. The coincident disappearance of the native heteronuclear single quantum coherence cross-peaks during the urea-denaturation process suggests that the residual structures observed contain no nativelike interactions. The protected residues (fold ons) in the urea-denatured state are mostly those that exchange slowly in the native state H/D exchange. The distribution of these fold ons in the native structure of hFGF-1 suggests that the refolding starts by collisions between the residual structures (microdomains) between the β-strands VI and VII, and between the β-strands II and III, which appear to be two independent refolding coordinates during the refolding process.

Indexed as

Protein DenaturationProtein RefoldingAmino AcidsAmino Acid SequenceDeuterium Exchange MeasurementFibroblast Growth Factor 1HumansHydrogen BondingMagnetic Resonance SpectroscopyModels, MolecularMolecular Sequence DataProtein Structure, SecondaryProtein UnfoldingUreaAmino AcidsFibroblast Growth Factor 1Urea

Identifiers

PMID21190667
PMCPMC3010829

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.